NEPTUNE clinical study

Living with Chronic Eye Pain?

Learn about the NEPTUNE clinical study evaluating an investigational treatment for Neuropathic Corneal Pain (NCP).

Neuropathic corneal pain can cause persistent pain, burning, stinging, or discomfort in the eyes, even when the eye looks relatively normal. This study is evaluating the safety and potential effectiveness of an investigational eye drop for adults with neuropathic corneal pain.

Now enrolling

About the Study

About the NEPTUNE Study

What is NCP?

Neuropathic corneal pain (NCP) is a chronic condition where nerves in the cornea become overly sensitive or damaged, leading to ongoing eye pain and discomfort. Common symptoms include:

 

Burning, stinging, or shooting pain in the eyes

Sensitivity to light (photophobia)

Foreign body sensation or dryness

Blurry or fluctuating vision

Persistent pain

About the NEPTUNE Study

Study Purpose

The NEPTUNE study is being conducted to evaluate the safety and potential effectiveness of an investigational treatment (urcosimod eye drops).

01

Study Overview

The NEPTUNE study (Neuropathic Eye Pain Treatment with Urcosimod & Nerve Evaluation) is a clinical research study evaluating an investigational eye drop for adults with neuropathic corneal pain.

This is a randomized, placebo-controlled study. This means that if you qualify and choose to participate, you will be randomly assigned (like a flip of a coin) to receive either the investigational treatment or a placebo (inactive eye drop that looks the same), and neither you nor the study team will know which one is being administered for the entire duration of the study.

02

Treatment Plan

Design

Participants are randomly assigned to receive either urcosimod eye drops or placebo eye drops, instilled 4 times per day.

Duration

The treatment period is ~12 weeks, with follow-up visits for monitoring. Participation in the study will last for ~17 weeks.

Visits

Regular study visits include eye examinations and other assessments to evaluate safety and study outcomes. Procedures are non-invasive or standard ophthalmic tests.

All study-related procedures, including the investigational drops, is provided at no cost to participants.

Am I Eligible

Eligibility Criteria

Eligibility will be assessed by participating study team. You may want to reach out if you are an adult 18 years or older and have been diagnosed with neuropathic corneal pain.

Eligibility Criteria

Exclusion Criteria

A study doctor will review your medical history and perform screening tests to determine eligibility.

18+

You can view the study criteria on clinicaltrials.gov using the study identifier NCT07838506.

Trial Locations

Find a Study Location

The NEPTUNE study will be conducted at multiple clinical sites across the United States and Europe, including Italy, Spain, and France.

To find out if a study location is near you or to learn more, contact a participating site directly.

UNited States

Bascom Palmer Eye Institute

900 NW 17th Street, Miami, Florida 33136

Not yet recruiting

Contact

Monica Arango

UNited States

University of South Florida

13330 USF Laurel Drive, 4th Floor, Tampa, FL, 33612

Not yet recruiting

Contact

Mya Reese

UNited States

New York University Langone

222 East 41st Street, 4th Floor, NY, NY 10017

Not yet recruiting

Contact

Quadis Evans

UNited States

University of Pennsylvania, Scheie Eye Institute

51 N 39th Street, Philadelphia, PA 19104

Not yet recruiting

Contact

Emma Iacobucci

UNited States

Toyos Eye Clinic

4200 Stammer Place, Nashville, TN 37215

Now recruiting

Contact

Harley Cheney

UNited States

Baylor College of Medicine, Alkek Eye Center

1977 Butler Blvd, 2nd Floor, Houston, TX 77030

Not yet recruiting

Contact

Carolyn Smith

UNited States

University of California Irvine, Gavin Herbert Eye Institute

850 Health Sciences Road, Irvine CA 92697-4375

Not yet recruiting

Contact

Rosie Magallo

UNited States

Boston Medical Center

1 Boston Medical Center Place, Boston, MA 02118

Not yet recruiting

Contact

Sree Alluri

Spain

Instituto de Oftalmobiología Aplicada University of Valladolid

Edificio IOBA, Campus Miguel Delibes. Paseo Belen 17. 47011 Valladolid, Spain

Not yet recruiting

Contact

Marta Blanco

Italy

Policlinico Umberto I

Viale del Policlinico, 155 – Rome, Italy

Not yet recruiting

Contact

Mattia D'Andrea

Italy

University of Rome

University Hospital, Via Álvaro del Portillo, 200, 00128 Roma RM, Italy

Not yet recruiting

Contact

Francesco Grande

France

Hopital Fondation A de Rothschild

25 Rue Manin, 75019 Paris, France

Not yet recruiting

Contact

Audrey Gilbert
Margaux Nedder

Italy

Universitaria Careggi

Largo Brambilla 3, 50134 Florence, Italy

Not yet recruiting

Contact

Rosa Perna
Matilde Conforti

Contact

For general questions about the NEPTUNE study or to express interest in participating, please reach out to a clinical study site near you.

FAQs

Frequently Asked Questions

What is a clinical trial?

A clinical trial is a research study conducted with patients and designed to evaluate the safety and effectiveness of a new treatment. A trial helps determine whether a new therapy is safe and works as intended.

What if I don’t see a study site near me?

please contact the study location listed that is closest to you

How long will I be in the study?

Up to 17 weeks

Who is conducting the trial?

OKYO Pharma